Gara Jalqabaatti › Dhukkuba Kroonii › Florida › Orlando
Qorannoo klinikaalii Dhukkuba Kroonii Orlando, FL keessatti
Qorannoo 17 Dhukkuba Kroonii f Orlando fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · Miili 16 fagaatti
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Namoota walitti qabaa jiraSadarkaa 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Namoota walitti qabaa jiraSadarkaa 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · Miili 16 fagaatti
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · Miili 24 fagaatti
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · Miili 16 fagaatti
- fi 1 dabalataa
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · Miili 16 fagaatti
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · Miili 16 fagaatti
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · Miili 16 fagaatti
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Namoota walitti qabaa jira
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Namoota walitti qabaa jiraQorannoo ilaalaa
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Namoota walitti qabaa jiraSadarkaa 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · Miili 16 fagaatti
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Namoota walitti qabaa jiraSadarkaa 2
- Mirador Therapeutics Selected Site, Orlando
Qorannoo Dhukkuba Kroonii magaalota biroo keessatti
- New York City, NYQorannoo 35
- Boston, MAQorannoo 19
- Miami, FLQorannoo 19
- Cleveland, OHQorannoo 19
- St. Louis, MOQorannoo 19
- Tyler, TXQorannoo 17
- Houston, TXQorannoo 17
- Atlanta, GAQorannoo 17
- San Antonio, TXQorannoo 15
- San Diego, CAQorannoo 15
- Los Angeles, CAQorannoo 15
- Colorado Springs, COQorannoo 13
Qorannoo biroo Orlando keessatti
- Kansara Qara'a Non-Small CellQorannoo 44
- ObesityQorannoo 32
- Kansara MetastatikiiQorannoo 29
- Baayyee UlfaataaQorannoo 27
- Dhukkubaa AlzheimerQorannoo 25
- Sukkaraa Gosa 2Qorannoo 25
- Saree (Gosoota Hunda)Qorannoo 24
- Saree OljooQorannoo 23
- Kansarii OvariiQorannoo 22
- Colitis UlcerativeQorannoo 22
- Dhibee QaraQorannoo 21
- Kansarii ColorectalQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.